Abstract
mTOR is a founding member of a family of protein kinases having catalytic domains homologous to those in phosphatidylinositol 3-OH kinase. mTOR participates in the control by insulin of the phosphorylation of lipin, which is required for adipocyte differentiation, and the two translational regulators, p70S6K and PHAS-I. The phosphorylation of mTOR, itself, is stimulated by insulin in Ser2448, a site that is also phosphorylated by protein kinase B (PKB) in vitro and in response to activation of PKB activity in vivo. Ser2448 is located in a short stretch of amino acids not found in the two TOR proteins in yeast. A mutant mTOR lacking this stretch exhibited increased activity, and binding of the antibody, mTAb-1, to this region markedly increased mTOR activity. In contrast, rapamycin-FKBP12 inhibited mTOR activity towards both PHAS-I and p70S6K, although this complex inhibited the phosphorylation of some sites more than that of others. Mutating Ser2035 to Ile in the FKBP12-rapamycin binding domain rendered mTOR resistant to inhibition by rapamycin. Unexpectedly, this mutation markedly decreased the ability of mTOR to phosphorylate certain sites in both PHAS-I and p70S6K. The results support the hypotheses that rapamycin disrupts substrate recognition instead of directly inhibiting phosphotransferase activity and that mTOR activity in cells is controlled by the phosphorylation of an inhibitory regulatory domain containing the mTAb-1 epitope.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Abbreviations
- cAMP:
-
Adenosine 3′,5′ cyclic phosphate
- eIF:
-
Eukaryotic initiation factor
- 4E-BP1:
-
eIF4E-binding protein 1
- FKBP-12:
-
FK506 binding protein of M r = 12,O0O
- GST:
-
Glutathione S transferase
- HEK:
-
Human embryonic kidney
- PHAS:
-
Phosphorylated heat- and acid-stable eIF4E-binding protein
- mTAb:
-
mTOR antibody
- mTOR:
-
Mammalian target of rapamycin
- PI 3-kinase:
-
Phosphatidylinositol 3-OH kinase
- PKB:
-
Protein kinase B
- p70S6K :
-
M r = 70,OOO ribosomal protein S6 kinase
References
Bondeva T, Pirola L, Bulgarelli-Leva G, Rubio I, Wetzker R, Wymann MP (1998) Bifurcation of lipid and protein kinase signals of PI3 K gamma to the protein kinases PKB and MAPK. Science 282:293–296
Brunn GJ, Fadden P, Haystead TAJ, Lawrence JC, Jr (1997a) The mammalian target of rapamycin phosphorylates sites having a (Ser/Thr)-Pro motif and is activated by antibodies to a region near its COOH-terminus. J Biol Chem 272:32547–32550
Brunn GJ, Hudson CC, Sekulic A, Williams, J.M., Hosoi H, Houghton, P.J., Lawrence JC, Jr., Abraham RT (1997b) Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science 277:99–101
Burnett PE, Barrow RK, Cohen NA, Snyder SH, Sabatini DM (1998) RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc Natl Acad Sci US A 95:1432–1437
Dennis PB, Pullen N, Kozma SC, Thomas G (1996) The principal rapamycin-sensitive p70s6k phosphorylation sites, T-229 and T-389, are differentially regulated by rapamycin-insensitive kinase kinases. Mol Cell Biol 16:6242–6251
Fadden P, Haystead TAJ, Lawrence JC, Jr (1997) Identification of phosphorylation sites in the translational regulator, PHAS-I, that are controlled by insulin and rapamycin in rat adipocytes. J Biol Chem 272:10240–10247
Gingras A-C, Gygi SP, Raught B, Polakiewicz RD, Abraham RT, Hoekstra MF, Aeber-sold R, Sonenberg N (1999a) Regulation of 4E-BP1 phosphorylation: a novel two step mechanism. Genes Dev 13:1422–1437
Gingras A-C, Raught B, Sonenberg N (1999b) eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Ann Rev Biochem 68:913–963
Graves LM, Bornfeldt KE, Argast GM, Krebs EG, Kong X, Lin T-A, Lawrence JC, Jr (1995) cAMP- and rapamycin-sensitive regulation of eukaryotic initiation factor 4E and the translational regulator PHAS-I in aortic smooth muscle cells. Proc Natl Acad Sci U S A 92:7222–7226
Gygi SP, Han DK, Gingras AC, Sonenberg N, Aebersold R (1999) Protein analysis by mass spectrometry and sequence database searching: tools for cancer research in the post-genomic era. Electrophoresis 20:310–319
Hara K, Maruki Y, Long X, Yoshino, K., Oshiro N, Hidayat T, Tokunaga C, Avruch J, Yonezawa K (2002) Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110:177–189
Hu C, Pang S, Kong X, Velleca M, Lawrence JC, Jr (1994) Molecular cloning and tissue distribution of PHAS-I, an intracellular target for insulin and growth factors. Proc Natl Acad Sci U S A 91:3730–3734
Huffman TA, Mothe-Satney I, Lawrence JC, Jr (2002) Insulin-stimulated phosphorylation of lipin mediated by the mammalian target of rapamycin. Proc Natl Acad Sci US A 99:1047–1052
Hunter T (1995) When is a lipid kinase not a lipid kinase? When it is a protein kinase. Cell 83:1–4
Kim D-H, Sarbasso DD, Ali SM, King JE, Latek RR, Erdjument-Bromage H, Tempst P, and Sabatini DM (2002) mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110:163–175
Kohn A, Barthel A, Kovacina KS, Boge A, Wallach B, Summers SA, Birnbaum M, Scott PH, Lawrence JC, Jr., Roth RA (1998) Construction and characterization of a conditionally active version of the Ser/Thr kinase Akt. J Biol Chem 273:11937–11943
Lin T-A, Kong X, Haystead TAJ, Pause A, Belsham G, Sonenberg N, Lawrence JC, Jr (1994) PHAS-I as a link between mitogen activated protein kinase and translation initiation. Science 266:653–656
Lin T-A, Kong X, Saltiel AR, Blackshear PJ, Lawrence JC, Jr (1995) Control of PHAS-I by insulin in 3T3-L1 adipocytes: synthesis, degradation, and phosphorylation by a rapamycin-sensitive and MAP kinase-independent pathway. J Biol Chem 270:18531–18538
Lin T-A, Lawrence JC, Jr (1996) Control of the translational regulators, PHAS-I and PHAS-II, by insulin and cAMP in 3T3-L1 adipocytes. J Biol Chem 271:30199–30204
McMahon LP, Choi K, Abraham RT, Lin T-A, Lawrence JC, Jr (2002) The rapamycin-binding domain governs substrate selectivity by the mammalian target of rapamycin. Mol Cell Biol in press
Monfar M, Lemon KP, Grammer TC, Cheatham L, Chung J, Vlahos CJ, Blenis J (1995) Activation of pp70/85 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP. Mol Cell Biol 15:326–337
Mothe-Satney I, Brunn GJ, McMahon LP, Capaldo CT, Abraham RT, Lawrence JC, Jr (2000a) Mammalian target of rapamycin-dependent phosphorylation of PHAS-I in four (S/T)P sites detected by phospho-specific antibodies. J Biol Chem 275:33836–33843
Mothe-Satney I, Yang D, Fadden P, Haystead TAJ, Lawrence JC, Jr (2000b) Multiple mechanisms control phosphorylation of PHAS-I in five (S/T)P sites that govern translational repression. Mol Cell Biol 20:3558–3567
Nave B, Ouwens M, Withers DJ, Alessi DR, Shepherd PR (1999) Mammalian target of rapamycin is a direct target for protein kinase B: Identification of a convergence point for opposing effects of insulin and amino acid deficiency on protein translation. Biochem J 344:427–431
Pause A, Belsham GJ, Gingras A-C, Donze O, Lin T-A, Lawrence JC, Jr., Sonenberg N (1994) Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5′-cap function. Nature 371:762–767
Peterfy M, Phan J, Xu P, Reue K (2001) Lipodystrophy in the fid mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nat Genet 27:121–124
Reynolds TH, Bodine S, Lawrence JC, Jr (2002) Control of Ser2448 phosphorylation in the mammalian target of rapamycin by insulin and skeletal muscle load. J Biol Chem 277:17657–17662
Saitoh M, Pullen N, Brennan P, Cantrell D, Dennis PB, Thomas G (2002) Regulation of an activated S6 kinase 1 variant reveals a novel mammalian target of rapamycin phosphorylation site. J Biol Chem 277:20104–20112
Schmelzle T, Hall MN (2000) TOR, a central controller of cell growth. Cell 103:253–262
Scott PH, Brunn GJ, Kohn AD, Roth RA, Lawrence JC, Jr (1998a) Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway. Proc Natl Acad Sci U S A 95:7772–7777
Scott PH, Lawrence JC, Jr (1998b) Attenuation of mammalian target of rapamycin activity by increased cAMP in 3T3-L1 adipocytes. J Biol Chem 273:34496–34501
Sekulic A, Hudson CC, Homme JL, Yin P, Otterness DM, Karnitz LM, Abraham RT (2000) A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin (mTOR) in mitogen-stimulated and transformed cells. Cancer Res 60:3504–3513
Tee AR, Proud CG (2002) Caspase cleavage of initiation factor 4E-binding protein 1 yields a dominant inhibitor of cap-dependent translation and reveals a novel regulatory motif. Mol Cell Biol 22:1674–1683
Yeh WC, Bierer BE, McKnight SL (1995) Rapamycin inhibits clonal expansion and adipogenic differentiation of 3T3-L1 cells. Proc Natl Acad Sci U S A 92:11086–11090
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lawrence, J.C., Lin, TA., McMahon, L.P., Choi, K.M. (2004). Modulation of the Protein Kinase Activity of mTOR. In: Thomas, G., Sabatini, D.M., Hall, M.N. (eds) TOR. Current Topics in Microbiology and Immunology, vol 279. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18930-2_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-18930-2_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62360-8
Online ISBN: 978-3-642-18930-2
eBook Packages: Springer Book Archive